April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2 mEq/mL, 20 mEq/10 mL vials, package of 25 (NDC 00409-6651-06)<br />
40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00409-7109-09)<br />
20 mEq/1000 mL in 0.45% sodium chloride (NDC 00409-9257-39)<br />
Reason for the Shortage<br />
• APP states the reason for the shortage is increased demand.<br />
• Hospira states the reason for the shortage is manufacturing delays.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=696<br />
Source: www.ashp.org<br />
Mannitol Injection<br />
March 21, <strong>2012</strong><br />
Products Affected - Description<br />
Mannitol injection, American Regent<br />
250 mg/mL, 50 mL vial, 25 count (NDC 00517-4050-25)<br />
Mannitol injection, APP<br />
250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25)<br />
Mannitol injection, Hospira<br />
250 mg/mL, 50 mL vial, 25 count (NDC 00409-4031-01)<br />
200 mg/mL, 250 mL premixed bag (NDC 00409-7715-02)<br />
200 mg/mL, 500 mL premixed bag (NDC 00409-7715-03)<br />
Reason for the Shortage<br />
• Hospira has mannitol injection on shortage due to manufacturing delays.<br />
• APP has mannitol injection on shortage due to increased demand for the product.<br />
• BBraun had mannitol injection on shortage due to increased demand for the product.<br />
• American Regent had temporarily suspended manufacture of most drug products in <strong>April</strong>, 2011.<br />
• American Regent resumed manufacturing in Shirley, New York in early-May, 2011.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=863<br />
Source: www.ashp.org<br />
Vitamin A Injection<br />
March 22, <strong>2012</strong><br />
Products Affected - Description<br />
Aquasol A, Hospira<br />
50,000 units/mL, 1 mL ampule (NDC 61703-0418-07)<br />
Reason for the Shortage<br />
• Hospira is changing manufacturing sites from a 3rd party manufacturer to in-house<br />
manufacturing. This has caused a delay in production.<br />
• Hospira is the sole manufacturer of vitamin A injection.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=704<br />
Source: www.ashp.org<br />
Orphenadrine Citrate Injection<br />
March 22, <strong>2012</strong><br />
Products Affected - Description<br />
Orphenadrine citrate injection, 30 mg/mL, Bedford<br />
2 mL vial, 10 count (NDC 55390-0059-10)<br />
Reason for the Shortage<br />
• Watson stated the shortage was due to production delays.<br />
56